India's Big Four Get U.S. Generics Market Competition Smaller Four
This article was originally published in PharmAsia News
Executive Summary
A new crop of India-based generics is making its presence felt in the U.S. market, providing stiff competition to the four leading India players, Dr. Reddy's laboratories, Lupin, Ranbaxy Laboratories and Sun Pharma.